Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24‐week, double‐blind, placebo‐controlled trial
Citations
705 citations
Additional excerpts
...Strojek et al, 2011 (64) Wilding et al, 2009 (66)...
[...]
...…(0.9) 9.4 (6.1) 87.4 (23.2) Sitagliptin plus metformin plus sulfonylurea 378 8.1 (0.9) 9.7 (6.3) 89.1 (23.2) Primary study: Strojek et al, 2011 (64) Extension study: Strojek et al, 2011 (65) 24 and 24 Journal article and RAR (primary); abstract (extension) Dapagliflozin, 10 mg, plus…...
[...]
...…al, 2011 (52) Leiter et al, 2012 (54) Ljunggren et al, 2012 (40) Matthews et al, 2012 (55) Rosenstock et al, 2012 (61) Rosenstock et al, 2012 (62) Strojek et al, 2011 (64) Wilding et al, 2009 (66) Wilding et al, 2012 (67) Wilding et al, 2012 (69) Wilding et al, 2013 (70) Yale et al, 2013…...
[...]
...…mg, plus metformin plus sulfonylurea 377 8.1 (0.9) 9.4 (6.1) 87.4 (23.2) Sitagliptin plus metformin plus sulfonylurea 378 8.1 (0.9) 9.7 (6.3) 89.1 (23.2) Primary study: Strojek et al, 2011 (64) Extension study: Strojek et al, 2011 (65) 24 and 24 Journal article and RAR (primary); abstract…...
[...]
667 citations
551 citations
442 citations
442 citations
Cites background from "Effect of dapagliflozin in patients..."
...of a medication that is associated with hypoglycaemia, like insulin or a sulphonylurea agent, an increase in hypoglycaemia is usually observed [19–23]....
[...]
References
21,148 citations
17,108 citations
3,807 citations
2,841 citations
"Effect of dapagliflozin in patients..." refers background in this paper
...In addition, the natural history of progressive loss of β-cell function during the course of T2DM reduces sulphonylurea long-term effectiveness [4]....
[...]
2,184 citations